Mosaic chromosomal alterations in blood across ancestries using whole-genome sequencing.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 04 11 2022
accepted: 27 09 2023
medline: 10 11 2023
pubmed: 31 10 2023
entrez: 31 10 2023
Statut: ppublish

Résumé

Megabase-scale mosaic chromosomal alterations (mCAs) in blood are prognostic markers for a host of human diseases. Here, to gain a better understanding of mCA rates in genetically diverse populations, we analyzed whole-genome sequencing data from 67,390 individuals from the National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine program. We observed higher sensitivity with whole-genome sequencing data, compared with array-based data, in uncovering mCAs at low mutant cell fractions and found that individuals of European ancestry have the highest rates of autosomal mCAs and the lowest rates of chromosome X mCAs, compared with individuals of African or Hispanic ancestry. Although further studies in diverse populations will be needed to replicate our findings, we report three loci associated with loss of chromosome X, associations between autosomal mCAs and rare variants in DCPS, ADM17, PPP1R16B and TET2 and ancestry-specific variants in ATM and MPL with mCAs in cis.

Identifiants

pubmed: 37904051
doi: 10.1038/s41588-023-01553-1
pii: 10.1038/s41588-023-01553-1
pmc: PMC10632132
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1912-1919

Informations de copyright

© 2023. The Author(s).

Références

Bick, A. G. et al. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature 586, 763–768 (2020).
pubmed: 33057201 pmcid: 7944936 doi: 10.1038/s41586-020-2819-2
Forsberg, L. A. et al. Age-related somatic structural changes in the nuclear genome of human blood cells. Am. J. Hum. Genet. 90, 217–228 (2012).
pubmed: 22305530 pmcid: 3276669 doi: 10.1016/j.ajhg.2011.12.009
Jacobs, K. B. et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nat. Genet. 44, 651–658 (2012).
pubmed: 22561519 pmcid: 3372921 doi: 10.1038/ng.2270
Laurie, C. C. et al. Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat. Genet. 44, 642–650 (2012).
pubmed: 22561516 pmcid: 3366033 doi: 10.1038/ng.2271
Loh, P.-R. et al. Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. Nature 559, 350–355 (2018).
pubmed: 29995854 pmcid: 6054542 doi: 10.1038/s41586-018-0321-x
Loh, P.-R., Genovese, G. & McCarroll, S. A. Monogenic and polygenic inheritance become instruments for clonal selection. Nature 584, 136–141 (2020).
pubmed: 32581363 pmcid: 7415571 doi: 10.1038/s41586-020-2430-6
Vattathil, S. & Scheet, P. Extensive hidden genomic mosaicism revealed in normal tissue. Am. J. Hum. Genet. 98, 571–578 (2016).
pubmed: 26942289 pmcid: 4800050 doi: 10.1016/j.ajhg.2016.02.003
Lin, S.-H. et al. Incident disease associations with mosaic chromosomal alterations on autosomes, X and Y chromosomes: insights from a phenome-wide association study in the UK Biobank. Cell Biosci. 11, 143 (2021).
pubmed: 34301302 pmcid: 8299574 doi: 10.1186/s13578-021-00651-z
Schick, U. M. et al. Confirmation of the reported association of clonal chromosomal mosaicism with an increased risk of incident hematologic cancer. PLoS ONE 8, e59823 (2013).
pubmed: 23533652 pmcid: 3606281 doi: 10.1371/journal.pone.0059823
Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477–2487 (2014).
pubmed: 25426838 pmcid: 4290021 doi: 10.1056/NEJMoa1409405
Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488–2498 (2014).
pubmed: 25426837 pmcid: 4306669 doi: 10.1056/NEJMoa1408617
Xie, M. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472–1478 (2014).
pubmed: 25326804 pmcid: 4313872 doi: 10.1038/nm.3733
Bonnefond, A. et al. Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications. Nat. Genet. 45, 1040–1043 (2013).
pubmed: 23852171 doi: 10.1038/ng.2700
Graham, E. J. et al. Somatic mosaicism of sex chromosomes in the blood and brain. Brain Res. 1721, 146345 (2019).
pubmed: 31348909 pmcid: 6717667 doi: 10.1016/j.brainres.2019.146345
Machiela, M. J. & Chanock, S. J. The ageing genome, clonal mosaicism and chronic disease. Curr. Opin. Genet. Dev. 42, 8–13 (2017).
pubmed: 28068559 pmcid: 5446794 doi: 10.1016/j.gde.2016.12.002
Terao, C. et al. Chromosomal alterations among age-related haematopoietic clones in Japan. Nature 584, 130–135 (2020).
pubmed: 32581364 pmcid: 7489641 doi: 10.1038/s41586-020-2426-2
Bloehdorn, J. et al. Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia. Nat. Commun. 12, 5395 (2021).
pubmed: 34518531 pmcid: 8438057 doi: 10.1038/s41467-021-25403-y
SEER*Explorer: An Interactive Website for SEER Cancer Statistics [Internet] (Surveillance Research Program, National Cancer Institute, 2023); https://seer.cancer.gov/statistics-network/explorer/
Chen, Y. et al. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival. BMC Med. Genomics 13, 116 (2020).
pubmed: 32819446 pmcid: 7441621 doi: 10.1186/s12920-020-00765-2
Ji, X. et al. Protein-altering germline mutations implicate novel genes related to lung cancer development. Nat. Commun. 11, 2220 (2020).
pubmed: 32393777 pmcid: 7214407 doi: 10.1038/s41467-020-15905-6
Germeshausen, M., Ballmaier, M. & Welte, K. MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease. Hum. Mutat. 27, 296 (2006).
pubmed: 16470591 doi: 10.1002/humu.9415
Jalas, C. et al. A founder mutation in the MPL gene causes congenital amegakaryocytic thrombocytopenia (CAMT) in the Ashkenazi Jewish population. Blood Cells Mol. Dis. 47, 79–83 (2011).
pubmed: 21489838 doi: 10.1016/j.bcmd.2011.03.006
Niroula, A. et al. Distinction of lymphoid and myeloid clonal hematopoiesis. Nat. Med. 27, 1921–1927 (2021).
pubmed: 34663986 pmcid: 8621497 doi: 10.1038/s41591-021-01521-4
Levin, M. G. et al. Genetics of smoking and risk of clonal hematopoiesis. Sci. Rep. 12, 7248 (2022).
pubmed: 35508625 pmcid: 9068754 doi: 10.1038/s41598-022-09604-z
Machiela, M. J. et al. Characterization of large structural genetic mosaicism in human autosomes. Am. J. Hum. Genet. 96, 487–497 (2015).
pubmed: 25748358 pmcid: 4375431 doi: 10.1016/j.ajhg.2015.01.011
Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature 590, 290–299 (2021).
pubmed: 33568819 pmcid: 7875770 doi: 10.1038/s41586-021-03205-y
Mitchell, E. et al. Clonal dynamics of haematopoiesis across the human lifespan. Nature 606, 343–350 (2022).
pubmed: 35650442 pmcid: 9177428 doi: 10.1038/s41586-022-04786-y
Saiki, R. et al. Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis. Nat. Med. 27, 1239–1249 (2021).
pubmed: 34239136 doi: 10.1038/s41591-021-01411-9
Franch-Expósito, S. et al. Associations between cancer predisposition mutations and clonal hematopoiesis in patients with solid tumors. JCO Precis. Oncol. 7, e2300070 (2023).
pubmed: 37561983 doi: 10.1200/PO.23.00070
Uddin, M. M. et al. Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics. Immun. Ageing 19, 23 (2022).
pubmed: 35610705 pmcid: 9128083 doi: 10.1186/s12979-022-00278-9
Fabre, M. A. et al. The longitudinal dynamics and natural history of clonal haematopoiesis. Nature 606, 335–342 (2022).
pubmed: 35650444 pmcid: 9177423 doi: 10.1038/s41586-022-04785-z
Mitchell, B. D. et al. The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study. Am. Heart J. 155, 823–828 (2008).
pubmed: 18440328 pmcid: 2443415 doi: 10.1016/j.ahj.2008.01.019
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am. J. Epidemiol. 129, 687–702 (1989).
Gottesman, O. et al. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet. Med. 15, 761–771 (2013).
pubmed: 23743551 pmcid: 3795928 doi: 10.1038/gim.2013.72
Hughes, G. H. et al. Recruitment in the Coronary Artery Disease Risk Development in Young Adults (CARDIA) Study. Control. Clin. Trials 8, 68S–73S (1987).
pubmed: 3440391 doi: 10.1016/0197-2456(87)90008-0
Fried, L. P. et al. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol. 1, 263–276 (1991).
pubmed: 1669507 doi: 10.1016/1047-2797(91)90005-W
Regan, E. A. et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 7, 32–43 (2010).
pubmed: 20214461 doi: 10.3109/15412550903499522
Splansky, G. L. et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute’s Framingham Heart Study: design, recruitment, and initial examination. Am. J. Epidemiol. 165, 1328–1335 (2007).
pubmed: 17372189 doi: 10.1093/aje/kwm021
Becker, D. M. et al. Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA 295, 1420–1427 (2006).
pubmed: 16551714 doi: 10.1001/jama.295.12.1420
Sorlie, P. D. et al. Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann. Epidemiol. 20, 629–641 (2010).
pubmed: 20609343 pmcid: 2904957 doi: 10.1016/j.annepidem.2010.03.015
Taylor, H. A. Jr et al. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn. Dis. 15, S6-4-17 (2005).
Bild, D. E. et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am. J. Epidemiol. 156, 871–881 (2002).
pubmed: 12397006 doi: 10.1093/aje/kwf113
Design of the Women’s Health Initiative clinical trial and observational study. The Women’s Health Initiative Study Group. Control. Clin. Trials 19, 61–109 (1998).
Fang, H. et al. Harmonizing genetic ancestry and self-identified race/ethnicity in genome-wide association studies. Am. J. Hum. Genet. 105, 763–772 (2019).
pubmed: 31564439 pmcid: 6817526 doi: 10.1016/j.ajhg.2019.08.012
Vattathil, S. & Scheet, P. Haplotype-based profiling of subtle allelic imbalance with SNP arrays. Genome Res. 23, 152–158 (2013).
pubmed: 23028187 pmcid: 3530675 doi: 10.1101/gr.141374.112
Maples, B. K., Gravel, S., Kenny, E. E. & Bustamante, C. D. RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference. Am. J. Hum. Genet. 93, 278–288 (2013).
pubmed: 23910464 pmcid: 3738819 doi: 10.1016/j.ajhg.2013.06.020
1000 Genomes Project Consortium et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).
Cavalli-Sforza, L. L. The Human Genome Diversity Project: past, present and future. Nat. Rev. Genet. 6, 333–340 (2005).
pubmed: 15803201 doi: 10.1038/nrg1579
Conomos, M. P., Miller, M. B. & Thornton, T. A. Robust inference of population structure for ancestry prediction and correction of stratification in the presence of relatedness. Genet. Epidemiol. 39, 276–293 (2015).
pubmed: 25810074 pmcid: 4836868 doi: 10.1002/gepi.21896
Conomos, M. P., Reiner, A. P., Weir, B. S. & Thornton, T. A. Model-free estimation of recent genetic relatedness. Am. J. Hum. Genet. 98, 127–148 (2016).
pubmed: 26748516 pmcid: 4716688 doi: 10.1016/j.ajhg.2015.11.022
Hu, Y. et al. Whole-genome sequencing association analysis of quantitative red blood cell phenotypes: the NHLBI TOPMed program. Am. J. Hum. Genet. 108, 874–893 (2021).
pubmed: 33887194 pmcid: 8206199 doi: 10.1016/j.ajhg.2021.04.003
Chen, H. et al. Control for population structure and relatedness for binary traits in genetic association studies via logistic mixed models. Am. J. Hum. Genet. 98, 653–666 (2016).
pubmed: 27018471 pmcid: 4833218 doi: 10.1016/j.ajhg.2016.02.012
Gogarten, S. M. et al. Genetic association testing using the GENESIS R/Bioconductor package. Bioinformatics 35, 5346–5348 (2019).
pubmed: 31329242 pmcid: 7904076 doi: 10.1093/bioinformatics/btz567
Gao, X., Starmer, J. & Martin, E. R. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet. Epidemiol. 32, 361–369 (2008).
pubmed: 18271029 doi: 10.1002/gepi.20310
Xiong, H. Y. et al. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease. Science 347, 1254806 (2015).
pubmed: 25525159 doi: 10.1126/science.1254806
Karczewski, K. J. et al. loftee. GitHub https://github.com/konradjk/loftee (2023).
Dong, C. et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum. Mol. Genet. 24, 2125–2137 (2015).
pubmed: 25552646 doi: 10.1093/hmg/ddu733
Fishilevich, S. et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database 2017, bax028 (2017).
pubmed: 28605766 pmcid: 5467550 doi: 10.1093/database/bax028
Zerbino, D. R., Wilder, S. P., Johnson, N., Juettemann, T. & Flicek, P. R. The ensembl regulatory build. Genome Biol. 16, 56 (2015).
pubmed: 25887522 pmcid: 4407537 doi: 10.1186/s13059-015-0621-5
National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services. The NHLBI BioData Catalyst. Zenodo https://doi.org/10.5281/zenodo.3822858 (2020).
Liu, X. et al. WGSA: an annotation pipeline for human genome sequencing studies. J. Med. Genet. 53, 111–112 (2016).
pubmed: 26395054 doi: 10.1136/jmedgenet-2015-103423
Heavner, B. wgsaparsr. GitHub https://github.com/UW-GAC/wgsaparsr (2020).
McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016).
pubmed: 27268795 pmcid: 4893825 doi: 10.1186/s13059-016-0974-4
Stilp, A. M. et al. A system for phenotype harmonization in the National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine (TOPMed) program. Am. J. Epidemiol. 190, 1977–1992 (2021).
pubmed: 33861317 pmcid: 8485147 doi: 10.1093/aje/kwab115

Auteurs

Yasminka A Jakubek (YA)

Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.

Ying Zhou (Y)

Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Adrienne Stilp (A)

Department of Biostatistics, University of Washington, Seattle, WA, USA.

Jason Bacon (J)

Department of Computer Science, Department of Biological Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.

Justin W Wong (JW)

Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Zuhal Ozcan (Z)

Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Donna Arnett (D)

University of South Carolina, Columbia, SC, USA.

Kathleen Barnes (K)

Division of Biomedical Informatics and Personalized Medicine, School of Medicine University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Joshua C Bis (JC)

Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.

Eric Boerwinkle (E)

Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Jennifer A Brody (JA)

Cardiovascular Health Research Unit, Department of Medicine, University of Washington Seattle, Seattle, WA, USA.

April P Carson (AP)

Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.

Daniel I Chasman (DI)

Brigham and Women's Hospital, Boston, MA, USA.

Jiawen Chen (J)

Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Michael Cho (M)

Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Matthew P Conomos (MP)

Department of Biostatistics, University of Washington, Seattle, WA, USA.

Nancy Cox (N)

Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Margaret F Doyle (MF)

Department of Pathology and Laboratory Medicine, The University of Vermont Larner College of Medicine, Colchester, VT, USA.

Myriam Fornage (M)

University of Texas Health Science Center at Houston, Houston, TX, USA.

Xiuqing Guo (X)

The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.

Sharon L R Kardia (SLR)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Joshua P Lewis (JP)

Department of Medicine, University of Maryland Baltimore, Baltimore, MD, USA.

Ruth J F Loos (RJF)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Xiaolong Ma (X)

Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.

Mitchell J Machiela (MJ)

National Institutes of Health, Bethesda, MD, USA.

Taralynn M Mack (TM)

Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Rasika A Mathias (RA)

Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MA, USA.

Braxton D Mitchell (BD)

Department of Medicine, University of Maryland Baltimore, Baltimore, MD, USA.

Josyf C Mychaleckyj (JC)

Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.

Kari North (K)

Department of Epidemiology, University of North Carolina Chapel-Hill, Chapel Hill, NC, USA.

Nathan Pankratz (N)

Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, USA.

Patricia A Peyser (PA)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Michael H Preuss (MH)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Bruce Psaty (B)

Cardiovascular Health Research Unit, Department of Medicine, Department of Epidemiology, Department of Health Systems and Population Health, University of Washington, Seattle, WA, USA.

Laura M Raffield (LM)

Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Ramachandran S Vasan (RS)

Department of Epidemiology, Boston University, Boston, MA, USA.

Susan Redline (S)

Division of Sleep Medicine, Harvard Medical School, Boston, MA, USA.

Stephen S Rich (SS)

Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.

Jerome I Rotter (JI)

The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.

Edwin K Silverman (EK)

Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Jennifer A Smith (JA)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Institute for Social Research, Survey Research Center, University of Michigan, Ann Arbor, MI, USA.

Aaron P Smith (AP)

Institute for Biomedical Informatics, University of Kentucky, Lexington, KY, USA.

Margaret Taub (M)

Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MA, USA.

Kent D Taylor (KD)

The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.

Jeong Yun (J)

Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Yun Li (Y)

Department of Biostatistics, Department of Genetics, Department of Computer Science, University of North Carolina Chapel-Hill, Chapel Hill, NC, USA.

Pinkal Desai (P)

Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Alexander G Bick (AG)

Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Alexander P Reiner (AP)

Department of Epidemiology, University of Washington, Seattle, WA, USA.

Paul Scheet (P)

Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. PAScheet@mdanderson.org.

Paul L Auer (PL)

Division of Biostatistics, Institute for Health and Equity, and Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA. pauer@mcw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH